N-{[4-(3-methylphenyl)-5-({2-[(5-methyl-1,3,4-thiadiazol-2-yl)amino]-2-oxoethyl}sulfanyl)-4H-1,2,4-triazol-3-yl]methyl}-4-(morpholine-4-sulfonyl)benzamide
Chemical Structure Depiction of
N-{[4-(3-methylphenyl)-5-({2-[(5-methyl-1,3,4-thiadiazol-2-yl)amino]-2-oxoethyl}sulfanyl)-4H-1,2,4-triazol-3-yl]methyl}-4-(morpholine-4-sulfonyl)benzamide
N-{[4-(3-methylphenyl)-5-({2-[(5-methyl-1,3,4-thiadiazol-2-yl)amino]-2-oxoethyl}sulfanyl)-4H-1,2,4-triazol-3-yl]methyl}-4-(morpholine-4-sulfonyl)benzamide
Compound characteristics
Compound ID: | A0062144 |
Compound Name: | N-{[4-(3-methylphenyl)-5-({2-[(5-methyl-1,3,4-thiadiazol-2-yl)amino]-2-oxoethyl}sulfanyl)-4H-1,2,4-triazol-3-yl]methyl}-4-(morpholine-4-sulfonyl)benzamide |
Molecular Weight: | 628.75 |
Molecular Formula: | C26 H28 N8 O5 S3 |
Smiles: | Cc1cccc(c1)n1c(CNC(c2ccc(cc2)S(N2CCOCC2)(=O)=O)=O)nnc1SCC(Nc1nnc(C)s1)=O |
Stereo: | ACHIRAL |
logP: | 1.9965 |
logD: | 1.9558 |
logSw: | -2.6572 |
Hydrogen bond acceptors count: | 15 |
Hydrogen bond donors count: | 2 |
Polar surface area: | 136.494 |
InChI Key: | ODNMGPSEFSOCQU-UHFFFAOYSA-N |